These are this morning’s top day trader and active trader alerts. We have more detailed data and analysis over at VSInvestor.com via links on each story and stock:
Apple Inc. (NASDAQ: AAPL) is still under a sell signal and under its 50-day moving average for the first time since April.
Sprint Nextel Corporation (NYSE: S) is up almost 5% on the Barron’s tout.
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) is the biggest loser on NASDAQ on an FDA negative response on Silenor.
Cell Therapeutics, Inc. (NASDAQ: CTIC) is trading up almost 6% on positive study data.
NVIDIA Corporation (NASDAQ: NVDA) and Advanced Micro Devices Inc. (NYSE: AMD) are big winners after Intel Corp. (NASDAQ: INTC) canceled the launch of its own graphics chipset.
You can join our open email distribution list to hear more news on key analyst calls, top day trader alerts, mergers and acquisitions, Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
Jon C. Ogg
RSS Updates
Email Updates
You might think that companies tend to repurchase fewer and fewer shares in their share buyback plans when shares rise and rise. When you compare the moves from the March 9 close, the price moves seem astronomical. Yet many shares are still under or close to where they were a year ago, and this seems to be keeping the flow of stock buyback announcements steady. We have tracked the major buyback announcements seen in November, and some are mere updates on what was reported along with the earnings reports seen this month.
Reuters: Senate Democrats unveiled their healthcare plan.









